The Role of MYC and PP2A in the Initiation and Progression of Myeloid Leukemias by Raffaella Pippa, Maria D. Odero

Get full text

Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells by Ion Cristóbal, Cristina Cirauqui, Remedios Castello-Cros, Laura Garcia-Orti, María J. Calasanz, María D. Odero

Get full text

Overexpression of SET is a recurrent event associated with poor outcome and contributes to protein phosphatase 2A inhibition in acute myeloid leukemia by Ion Cristóbal, Laura Garcia-Orti, Cristina Cirauqui, Xabier Cortes-Lavaud, María A. García-Sánchez, María J. Calasanz, María D. Odero

Get full text

In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia by Kim De Keersmaecker, Idoya Lahortiga, Nicole Mentens, Cedric Folens, Leander Van Neste, Sofie Bekaert, Peter Vandenberghe, Maria D. Odero, Peter Marynen, Jan Cools

Get full text

CIP2A high expression is a poor prognostic factor in normal karyotype acute myeloid leukemia by Eva Barragán, María Carmen Chillón, Remedios Castelló-Cros, Nerea Marcotegui, María Isabel Prieto, Montserrat Hoyos, Raffaella Pippa, Marta Llop, Amaia Etxabe, José Cervera, Gabriela Rodríguez, Ismael Buño, José Rifón, Jorge Sierra, Marcos González, María J. Calasanz, Miguel A. Sanz, María D. Odero

Get full text

Down-regulation of EVI1 is associated with epigenetic alterations and good prognosis in patients with acute myeloid leukemia by Iria Vázquez, Miren Maicas, José Cervera, Xabier Agirre, Oskar Marin-Béjar, Nerea Marcotegui, Carmen Vicente, Idoya Lahortiga, Maria Gomez-Benito, Claudia Carranza, Ana Valencia, Salut Brunet, Eva Lumbreras, Felipe Prosper, María T. Gómez-Casares, Jesús M. Hernández-Rivas, María J. Calasanz, Miguel A. Sanz, Jorge Sierra, María D. Odero

Get full text